Alzheimer's drugs are medications used to manage symptoms and slow the progression of Alzheimer’s disease. They primarily include cholinesterase inhibitors, which boost levels of acetylcholine, and NMDA receptor antagonists, which regulate glutamate activity. New therapies are also being developed to target the disease’s underlying pathology.
Alzheimer Drugs Market Size
The Global Alzheimer Drugs Market reached USD 3.97 billion in 2022 and is projected to witness lucrative growth by reaching USD 7.7 billion by 2031. The Global Alzheimer Drugs Market is expected to exhibit a CAGR of 8.7% during the forecast period 2024-2031.
The scope of the global Alzheimer’s drugs market encompasses various drug types, including rivastigmine, donepezil, and galantamine, which contribute to the growing market share for Alzheimer’s medications. Additionally, the use of biomarkers in drug discovery is on the rise and is a major focus of ongoing research.
Request for free sample:https://www.datamintelligence.com/download-sample/alzheimer-drugs-market
Alzheimer Drugs Market Dynamics
The growth of the global Alzheimer’s drugs market is being driven by several factors, including the increasing research into Alzheimer’s medications, the use of biomarkers in drug development, a growing geriatric population, and the introduction of innovative and technologically advanced therapies.
The expansion of the market is further fueled by extensive research efforts focused on Alzheimer's disease. For example, in October 2020, the Alzheimer's Association awarded USD 1,000,000 to ImmunoBrain Checkpoint to support the Phase I clinical trial of "IBC-Ab002" as a potential treatment for Alzheimer’s.
Get your customized report @https://www.datamintelligence.com/customize/alzheimer-drugs-market
Alzheimer's Drugs Market is segmented
By Drugs Type: Donepezil, Galantamine, Rivastigmine, Memantine
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Sales
By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa
Alzheimer Drugs Market Companies
- F. Hoffmann-La Roche
- Novartis AG
- Merck & Co.
- Pfizer Inc.
- Eli Lilly and Co.
- Biogen Inc.
- Johnson & Johnson
- Lupin
- Siemens Healthineers
- AbbVie
Related Reports
Deep Brain Stimulation Devices Market
Brain Health Supplements Market
Neurorehabilitation Devices Market
Contact Us:
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Contact Person: Sai. K
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across
